DUBLIN, March 23, 2021 / PRNewswire / – Added Report “Allergic Immunotherapies Market: Global Industry Trend, Share, Size, Growth, Opportunity and Forecast 2021-2026” ResearchAndMarkets.com’s offering.
The global market for allergic immunotherapies has reached a value of US $ 2.3 Billion in 2020. Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a protective medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollen and household dust mites. It alters the immune system response by gradually increasing the doses of the allergen. Prior to the start of treatment, an allergist and a patient examine for stimulatory factors for allergy symptoms, which may include skin and blood tests to determine the allergens. Allergy immunotherapy helps reduce inflammation, offers long-term effects, increases immunological tolerance, alters the course of the disease and improves the quality of life of the patient.
In the last few years, there has been an increase in the incidence of allergies worldwide due to a number of environmental and lifestyle factors that affect the activity of the immune system. With the growing awareness of allergic immunotherapies, rising income levels and rising health care spending, the demand for solemn and long-term treatment options is increasing, and that then stimulates market growth. It is also supported by the rising clinical research and development budget as a result of a number of initiatives taken by government and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical companies have created more effective immunotherapies for the successful treatment of several allergens. This, coupled with advances in the field of allergy diagnosis, catalyzes the growth of the global allergy immunotherapies market. Looking ahead, the publisher expects the global market for allergy immunotherapies to reach a value of $ 4.10 billion US by 2026, exhibiting a CAGR of 10.50% in 2021-2026.
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players such as ALK-Abello A / S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics , Circassia Pharmaceuticals, Anergis SA, Biomay AG, etc.
Key questions answered in this report:
- How has the global immunotherapies market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global allergy vaccine industry?
- What is the impact of COVID-19 on the global allergy vaccine industry?
- What is a market disruption based on the type of treatment?
- What is a market break based on the type of allergy?
- What is the market breakdown based on the distribution channel?
- What are the different levels of global allergy immunotherapies industry value chain?
- What are the key drivers and challenges in the global allergy vaccination industry?
- What is the structure of the global allergy immunotherapies industry and who are the key players?
- What is the level of competition in the global allergy immunotherapies industry?
- What are the profit margins in the global allergy immunotherapies industry?
Key topics covered:
1 Introduction
2 Scope and Approach
2.1 Aims of the study
2.2 Stakeholders
2.3 Data sources
2.3.1 Key Sources
2.3.2 Secondary Sources
2.4 Market measurement
2.4.1 Bottom up approach
2.4.2 A top-down approach
2.5 Preview Procedure
3 Executive Minutes
4 Introduction
4.1 Outlook
4.2 Key industry trends
5 Global Allergy Immunotherapies Market
5.1 Market outlook
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market breakdown by type of treatment
5.5 Market breakdown by type of allergy
5.6 Market breakdown by circulation channel
5.7 Market breakdown by area
5.8 Market forecast
6 Market breakdown by type of treatment
6.1 Subcutaneous Immunotherapy (SCIT)
6.1.1 Market trends
6.1.2 Market outlook
6.2 Sublingual Immunotherapy (SLIT)
6.2.1 Market trends
6.2.2 Market forecast
7 Market breakdown by type of allergy
7.1 Allergic rhinitis
7.1.1 Market trends
7.1.2 Market outlook
7.2 Asthma
7.2.1 Market trends
7.2.2 Market forecast
7.3 Food Allergy
7.3.1 Market trends
7.3.2 Market forecast
7.4 Venom Allergy
7.4.1 Market trends
7.4.2 Market forecast
7.5 Other
7.5.1 Market trends
7.5.2 Market outlook
8 Market breakdown with circulation channel
8.1 The Hospital Pharmacy
8.1.1 Market trends
8.1.2 Market outlook
8.2 Retail Pharmacy
8.2.1 Market trends
8.2.2 Market forecast
8.3 Online Pharmacy
8.3.1 Market trends
8.3.2 Market forecast
9 Market breakdown by area
9.1 Europe
9.1.1 Market trends
9.1.2 Market outlook
9.2 North America
9.2.1 Market trends
9.2.2 Market forecast
9.3 Asia Pacific
9.3.1 Market trends
9.3.2 Market forecast
9.4 Middle East and Africa
9.4.1 Market trends
9.4.2 Market forecast
9.5 Latin America
9.5.1 Market trends
9.5.2 Market forecast
10 SWOT review
10.1 Preview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Risks
11 Value chain analysis
12 Five Force Porters Survey
12.1 Preview
12.2 Buyer’s bargaining power
12.3 Bargaining power of suppliers
12.4 Competition Level
12.5 Risk of New Entrants
12.6 Agent Risk
13 Price Review
13.1 Price Indicators
13.2 Pricing Structure
13.3 Margin Survey
14 Competitive Landscape
14.1 Market Structure
14.2 Key players
14.3 Profiles of key players
14.3.1 ALK-Abello A / S.
14.3.2 Allergy Remedy
14.3.3 Greim Stallergenes
14.3.4 HAL Allergy Group
14.3.5 DBV Technologies
14.3.6 Merck Group
14.3.7 Immune Medicine
14.3.8 Circassia Medicines
14.3.9 Anergis SA
14.3.10 Biomay AG
For more information about this report, visit https://www.researchandmarkets.com/r/4ol98g
Contact the media:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For EST Office Hours Call + 1-917-300-0470
For US / CAN Toll Free Call + 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com